FDA Approval Summary: Sonidegib—Response

Race and ethnicity are important considerations during drug development, with differential effects in drug exposure, efficacy, and safety across racial groups observed for some drugs. Gyawali and Ando ([1][1]) suggest that the recommended dose of 200 mg once daily for sonidegib may not be